申请人:Bjorsne Magnus
公开号:US20050004113A1
公开(公告)日:2005-01-06
There is provided compounds of formula I,
wherein R
1
, R
2
, R
3
, R
4
, R
5a
, R
5b
, R
5c
, R
5d
, R
5e
, R
5f
, R
6
, X, A, B and D have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
提供了式I的化合物,其中R1、R2、R3、R4、R5a、R5b、R5c、R5d、R5e、R5f、R6、X、A、B和D的含义如描述中所述,这些化合物在预防和治疗心律失常方面有用,特别是房性和室性心律失常。